Overview

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants

Status:
Completed

Trial end date:
2014-05-22

Target enrollment:

Participant gender:

Summary

This study is to evaluate the safety, pharmacokinetics/pharmacodynamics (PK/PD), food-effect, and drug-drug interaction study of ACP-196 in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Acerta Pharma BV

Treatments:

Acalabrutinib
Itraconazole